Celcuity CELC
NASDAQ CELC
$95.70 -0.73 (-0.76%)
As of: Sep 4, 2026 · 3:59 PM EDT

Celcuity (CELC) Free Cash Flow (2016 - 2025)

Celcuity's (CELC) quarterly Free Cash Flow came in at -$36.5 million in Q4 2025, down 31.05% YoY from -$52.9 million in Q4 2024, and up 18.84% on a QoQ basis from -$44.9 million in Q3 2025.

Analysis

Celcuity (CELC) Free Cash Flow (2016 - 2025) Analysis & Trends

Celcuity (CELC) has 10 years of Free Cash Flow data on file, last reported at -$36.5 million in Q4 2025.

  • Quarterly Free Cash Flow fell 31.05% year-over-year to -$36.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$153.5 million (down 83.39% YoY) and the FY2025 annual result came in at -$153.5 million, down 83.39% from the prior year.
  • Free Cash Flow climbed to -$36.5 million in Q4 2025, from -$44.9 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of -$2.6 million in Q1 2021 to a low of -$44.9 million in Q3 2025.
  • A 5-year average of -$17.4 million and a median of -$12.8 million in 2023 frame the typical range for Free Cash Flow.
  • Annual changes were most pronounced in 2021 — Free Cash Flow plunged 384.75% — and 2023, when it gained 14.54%.
  • Tracing CELC's Free Cash Flow over 5 years: stood at -$6.1 million in 2021, then tumbled by 56.36% to -$9.6 million in 2022, then sank by 93.6% to -$18.6 million in 2023, then slumped by 49.8% to -$27.8 million in 2024, then slumped by 31.05% to -$36.5 million in 2025.
  • The last three Free Cash Flow figures came in at -$36.5 million (Q4 2025), -$44.9 million (Q3 2025), and -$36.3 million (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Free Cash Flow (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.01 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 572.80 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -563.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -389.61 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 437.80 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 292.04 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 477.44 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -95.09 Mn
10 Celcuity 5.25 Bn 5.25 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -36.45 Mn
Sep 30, 2025 -44.91 Mn
Jun 30, 2025 -36.25 Mn
Mar 31, 2025 -35.91 Mn
Dec 31, 2024 -27.82 Mn
Sep 30, 2024 -20.61 Mn
Jun 30, 2024 -18.13 Mn
Mar 31, 2024 -17.16 Mn
Dec 31, 2023 -18.57 Mn
Sep 30, 2023 -12.80 Mn
Jun 30, 2023 -9.67 Mn
Mar 31, 2023 -12.87 Mn
Dec 31, 2022 -9.59 Mn
Sep 30, 2022 -9.32 Mn
Jun 30, 2022 -11.31 Mn
Mar 31, 2022 -5.94 Mn
Dec 31, 2021 -6.13 Mn
Sep 30, 2021 -4.06 Mn
Jun 30, 2021 -7.64 Mn
Mar 31, 2021 -2.55 Mn